Australia's most trusted
source of pharma news
Friday, 5 December 2025
Friday, 5 December 2025
Subscribe
Login
TGA considers $4M treatment
The TGA is reviewing what could become one the most expensive treatments in Australia - a new form of a Novartis therapy which carries a price tag of $4 million for a one-time dose.
$57M patent lost, more to follow?
An appeal to reinstate a patent has been denied by the Full Federal Court, but the reasons may place other drugs at risk
TODAY
PBS listing delivers gift of time
December reimbursement means treatment time for these patients will be slashed from three hours to just 10 minutes
TODAY
What really drives Dr prescribing?
New survey dives deep into what's really driving prescribing decisions made by Australian doctors, and what makes them switch treatment
4 December
Another Country Leader named
The third new Australian Country Leader to be named in the space of 24 hours with a local exec appointed General Manager
3 December
Industry body shuts over funding
After 10 years, this high-profile organisation has been forced to close its doors due to funding challenges
3 December
Two new Country Heads appointed
So that's where they've gone... two familiar faces in Aussie pharma land new leadership positions after much speculation
2 December
Latest Jobs
Senior Recruitment ConsultantMedical information and governance associateMedical ManagerFinance & Admin OfficerSpecialist Account ManagerKey Account ManagerDevices Territory ManagerSenior Product Manager27 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (14)
- Specialist Account Manager - Sydney
- Key Account Manager - Sydney
- Devices Territory Manager - Brisbane
- Clinical Research, Business Development Manager - China - Shanghai, China
- Medical Sales Representative - Wollongong
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Brisbane
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Belrose
Clinical & Medical, R&D (8)
- Medical information and governance associate - Sydney
- Medical Manager - Sydney
- Clinical Research, Business Development Manager - China - Shanghai, China
- Medical Sales Representative - Wollongong
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
Regulatory, Pharmacovigilance & QA (3)
- Regulatory Affairs Specialist - Sydney
- Senior Quality Assurance Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
Devices (1)
Executive Roles (3)
- Compliance & Legal Director - Macquarie Park
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
Other (14)
- Senior Recruitment Consultant - Sydney
- Finance & Admin Officer - Macquarie Park
- Service Administrator - Belrose
- Warehouse Assistant - Rydalmere
- Freight & Distribution Specialist - Macquarie Park
- Technical Service & Warehouse Coordinator - Alexandria
- Finance Business Partner - Surry Hills
- Senior Payroll Officer - Melbourne
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
- Senior Recruitment Consultant - Sydney
- Warehouse Assistant - Macquarie Park
- Senior Recruitment Consultant - Sydney
Lilly collabs with Aussie superstar
Partners with Aussie Hollywood heart throb to create a TV special raising awareness about Alzheimer's disease
4 December
Novo team pedals to $100K
Aussie staffers riding high after surpassing their fundraising goal in a gruelling charity event for research into type 1 diabetes
4 December
Ex-MA boss launches new venture
Enters partnership to introduce an AI-driven healthcare performance and funding tool into Australia to underpin system reform
4 December
Rare disease renovation required
New report calls for Govt to establish an Office of Rare Disease alongside other recommendations to improve treatment in rare
4 December
MS cases and costs skyrocket
New report finds a record number of Australians are living with the disease and the significant burden economic as well as physical
3 December
Aussies take on J&J in big market
Melbourne company thinks it can take market share in a multi-billion dollar space held exclusively in Australia by J&J
3 December
Butler cuts ribbon on $1B CSL plant
New vaccine and antivenom manufacturing facility is the first of its kind in the Southern Hemisphere
3 December
Trump gunning for Australia next?
The UK has agreed to up what it pays for novel medicines by 25% now Trump is looking to do similar deals with other trading partners
2 December
Gilead names community champs
After a record number of nominations, five Aussies have been recognised for their support and advocacy for those with HIV
2 December
Who's won 2025's last PBS listings?
With the year's reimbursement run concluded, seven companies have laid claim to the final listings including a next-gen PD-1 inhibitor
2 December New to the PBS
New podcast tackles AI in pharma
Experts unpack all the transformational changes from drug development to how companies will connect with doctors and patients
2 December
PBS listing gift kicks off December
The last reimbursement announcements of 2025 commence. See which company was first with news of a listing
1 December
It's over: 40-year partnership ends
Distribution of two high-profile vaccines on the NIP has changed hands, ending a deal older than one of the companies involved
1 December
First generic lands on ARTG
Drug treating a common ailment faces its first generic competition, while the TGA ticks more challengers to big names
1 December Approvals Action